Background and Purpose: In small arteries, SK Ca and IK Ca channels restricted to the vascular endothelium generate hyperpolarization that underpins the NO-and PGI 2 -independent, EDHF response that is the predominate endothelial mechanism for vasodilatation. As neuronal IK Ca channels can be negatively regulated by PKA, we investigated whether β-adrenoceptor stimulation, which signals through cAMP/PKA, might influence endothelial cell hyperpolarization and as a result modify the associated vasodilatation. 
Introduction
Vascular endothelial cells contain two forms of K Ca channel, the small and intermediate conductance Ca 2+ -activated potassium channels (SK Ca and IK Ca , respectively; (Edwards et al., 1998) . The SK Ca and IK Ca channels can be regulated independently to generate endothelial cell hyperpolarization (Crane et al., 2003) , reflecting a differential distribution of the two subtypes within the cell membrane (Dora et al., 2008) . Activated by increases in endothelial cell [Ca 2+ ], they generate hyperpolarization that spreads to relax the adjacent smooth muscle. Historically this effect was defined as the EDHF response, because it was thought solely to reflect the action of a diffusible hyperpolarizing factor. It is now clear that hyperpolarization spreads to the muscle partly through myo-endothelial gap junctions (MEGJs) and partly via a diffusible factor that in the mesenteric artery is K + effluxing through the K Ca channels. As such the term, EDH is now used to describe this complex NO/PGI 2 -independent signalling pathway, that is a predominate endothelial influence on function in small arteries where the smooth muscle cells express voltage-dependent Ca 2+ -channels in high density (reviewed by Garland et al., 2011a) .
We have previously shown that the activation of adenylyl cyclase (with forskolin) can selectively suppress the IK Ca (not SK Ca ) channel component of EDH during endothelial cell stimulation with ACh in mesenteric resistance arteries (Dora et al.,
9
previously described (Garland & McPherson, 1992; Garland et al., 2011b) . Membrane potential was recorded through a pre-amplifier (Neurolog system, Digitimer Ltd., U.K.) linked to a MacLab data acquisition system (AD Instruments Model 4e, usually at 100 Hz). All drugs were added directly to the bath.
Measurement of endothelial cell sheet membrane potential
For patch clamp studies, endothelial cells were isolated from mesenteric arteries that
had been cut open and placed in nominally Ca 2+ -free physiological saline solution (HEPES-PSS) containing (mM): 130 NaCl, 5 KCl, 1.2 MgCl 2 , 10 glucose, 10 HEPES (pH adjusted to 7.4 with NaOH) with the additional presence of 1 mg/ml papain, 1mg/ml bovine serum albumin (BSA, fraction V) and 1 mg/ml dithiothreitol for 10 min at room temperature and then for 30 min at 36º C. The arteries were then washed in Ca
2+
-free BSA-containing HEPES-PSS and gently triturated to release endothelial cells. Cell suspensions were stored on ice (the Ca 2+ concentration was gradually increased to 0.5 mM) and used on the same day. All patch-clamp recordings were performed in HEPES-PSS containing 1 mM CaCl 2 , 100 µM L-NAME and 10 µM indomethacin. The recording pipette solution contained (mM): 140 KCl, 2 MgATP, 0.1 Na 2 GTP, 0.5 MgCl 2 , 10 HEPES, 0.1 EGTA, pH adjusted to 7.2 with KOH.
Membrane potential was recorded from endothelial cell sheets (containing between 3 and >20 cells) using the current clamp mode of the whole-cell patch clamp technique at sampling rate 10 Hz (Axoclamp 200B amplifier; Axon Instruments, Union City, CA, USA). Pipette resistance, when filled with pipette solution, was 5-10 MΩ. 
Measurement of endothelial [

Drugs and solutions
All drugs were obtained from Sigma (Poole, UK) with the exception of apamin (Latoxan, France), and forskolin (Biomol International). U46619, TRAM-34 (1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole) and forskolin were dissolved in dimethyl sulfoxide, while adrenaline and noradrenaline bitartrate salts were dissolved in 10 -4 M ascorbic acid. All other stock solutions were prepared using purified (MilliQ) water.
All stock solutions were prepared at 10 -2 M, except for L-NAME (10 -1 M), and subsequently diluted in MOPS buffer (pressurized arteries), Krebs buffer (wire myograph) or HEPES-PSS (patch clamp). Inhibitors were pre-incubated with the arterial tissue for at least 20 mins before agonist application.
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Results
Intraluminal perfusion of β-adrenoceptor agonists inhibits endothelium-dependent dilatation to ACh
In pressurized small mesenteric arteries pre-contracted with PE, ACh (1 nM to 10 µM) stimulated concentration-dependent dilatation (pEC 50 = 7.1 ± 0.02, n = 5; Figure   1A ). When either adrenaline or NA (1 µM) were luminally perfused in PE precontracted arteries, neither stimulated contraction, even in the presence of propranolol
(1 µM, n = 4-9). However the luminal perfusion of β-adrenoceptor agonists reversibly inhibited ACh-mediated dilatation. Isoprenaline (1 µM), NA (1 µM) or adrenaline (0.5 µM) each right-shifted ACh concentration response curves (isoprenaline: from pEC 50 = 7.2 ± 0.01 to pEC 50 = 6.4 ± 0.03, n = 6, P<0.05, Figure 1B ; NA: to pEC 50 = 6.4 ± 0.3, n = 6, P<0.05, Figure 1C ; adrenaline: to pEC 50 = 6.6 ± 0.02, n = 6, P<0.05, Figure 1D ). Inhibition of dilatation to ACh was mimicked by activation of adenylyl cyclase by luminal perfusion of forskolin (0.5-1 µM; from pEC 50 = 7.2 ± 0.02 to pEC 50 = 6.5 ± 0.03, n = 5, P<0.05; Figure 1E ). In contrast to the action of β-adrenoceptor agonists, luminal perfusion of either MOPS buffer alone or the α 1 -adrenoceptor agonist, PE (0.5 µM, n = 5), did not modify responses to ACh.
The ability of isoprenaline to inhibit endothelium-dependent dilatation to ACh was blocked by pre-treatment of arteries with the PKA inhibitor KT 5720 that alone had no effect (1 µM; Figure 2A ), but not by the K ATP channel blocker glibenclamide (10 µM, Figure 2B ). Glibenclamide was used to prevent the hyperpolarization that is stimulated by isoprenaline through the opening of smooth muscle K ATP channels in this artery, a change that could potentially interfere with EDH-mediated hyperpolarization to ACh by decreasing the driving force for K + efflux. In 1 mM [Ca 2+ ] o Krebs, ACh evoked concentration-dependent smooth muscle hyperpolarization (from a resting potential of -54.2 ± 1.8 mV, by a maximum of 20.9 ± 1.1 mV, pEC 50 = 7.2 ± 0.11, n = 5). In the presence of 10 µM glibenclamide, to block β-adrenoceptor-stimulated hyperpolarization, isoprenaline (1 µM) significantly suppressed the smooth muscle hyperpolarization to ACh (decreased to a maximum of 13.1 ± 1.3 mV, from a resting potential of -53.8 ± 0.9 mV, n = 5; Figure 3A top (i) and middle trace (ii) & 3B). The ACh-hyperpolarization that persisted in the presence of isoprenaline was mediated by SK Ca , as it was blocked by 50 nM apamin ( Figure 3A bottom trace (iii), summary data Figure 3B ). Apamin alone depressed AChhyperpolarization to a similar extent to isoprenaline ( Figure Figure 3B , n = 6).
Atenolol did not alter the concentration-dependent hyperpolarization to ACh in the presence of apamin (maximum of 13.5 ± 1.9 mV, n = 5).
In freshly isolated endothelial cell sheets incubated with apamin, ACh (1 µM) applied for 30 s every 5 mins evoked reproducible and reversible hyperpolarization that was blocked in a time dependent manner with isoprenaline (1 µM, Figure 3C and summarized in Figure 3D ). These data demonstrate the presence of functional β-adrenoceptors in endothelial cells of mesenteric arteries, and confirm their role in suppressing the ability of ACh to activate endothelial cell IK Ca channels.
Endothelial IK Ca channels underlie β-adrenoceptor inhibition of endotheliumdependent hyperpolarization
Noradrenaline suppressed ACh-hyperpolarization to a similar extent as isoprenaline.
In 1 mM [Ca 2+ ] o Krebs, ACh stimulated a maximum hyperpolarization of 20.5 ± 1.7 mV (pEC 50 = 7.0 ± 0.03, initial membrane potential -51.5 ± 0.7 mV, n = 8). In the presence of prazosin (1 µM, to block α 1 -adrenoceptors) and glibenclamide, NA (1 µM) suppressed hyperpolarization (maximum now 11.1 ± 1.8 mV from a resting potential of -52.6 ± 0.7 mV, n = 5; Figure Figure   4D ). In 2.5 mM [Ca 2+ ] o , ACh-mediated hyperpolarization is entirely due to SK Ca channel activation (Crane et al., 2003; Dora et al., 2008) .
Endothelial IK Ca channels underlie β-adrenoceptor inhibition of endotheliumdependent dilatation to ACh
As shown previously, inhibition of NO synthase right-shifted the concentrationresponse curve to ACh without depressing the maximum response (100 µM L-NAME, pEC 50 from 7.2 ± 0.04 to 6.8 ± 0.1, n = 6, P<0.05). The residual dilatation is due to hyperpolarization (EDH-dilatation, Crane et al., 2003) , and was reduced by apamin (50 nM; pEC 50 = 6.2 ± 0.1, n = 6, P<0.05), then markedly suppressed by the subsequent addition of TRAM-34 (1 µM, n = 5, P<0.05; Figure 5A ).
EDH dilatation obtained in the presence of L-NAME was suppressed by luminal perfusion of NA (from pEC 50 = 6.8 ± 0.02 to pEC 50 = 6.2 ± 0.03, n = 4, P<0.05;
Figure 5B Figure 7C (ii) and 7D).
Accepted Article (Fujii et al., 1999; Takano et al., 2004; White & Hiley, 2000b) .
The observation that β 1 -adrenoceptors appear to account for the inhibition of IK Ca channels by catecholamines ties these receptors to endothelial cells, as IK Ca channels are not expressed in the smooth muscle cells of this artery (Walker et al., 2001 ). This β 1 rather than β 2 -adrenoceptors predominate in the mesenteric artery (Briones et al., 2005; Garland et al., 2011b) . This is in itself interesting, because although both receptor subtypes associate with caveolae, the β 1 -adrenoceptor is more widely distributed through the cell membrane and known to associate with extra-caveolar cell fractions, at least in cardiac myocytes (Rybin et al., 2000) . β 1 -adrenoceptors may therefore reside in membrane regions that also contain IK Ca channels. If β 1 -adrenoceptors do align in close proximity to the IK Ca channels in endothelial cell projections, they will be ideally placed to influence the activity of these strategically positioned K-channels.
The fact that β 1 -adrenoceptor stimulation can inhibit endothelial cell IK Ca channels, and as a result depress EDH-mediated vasodilatation, seems strange as β 1 -adrenoceptors also evoke potent smooth muscle relaxation that is associated with and in part reflects hyperpolarization (Garland et al., 2011c) . However, the hyperpolarization caused by β 1 -adrenoceptors is entirely due to K ATP channel activation, and at least in the mesenteric artery these channels are only present on the smooth muscle, not on endothelial cells (Takano et al., 2004; White & Hiley, 2000a) .
One possibility, is that in vivo endothelial IK Ca channels are influenced primarily by circulating β-adrenoceptor agonists, so at least in mesenteric vessels the depression of endothelial function enhances vasoconstriction. et al., 2002; Kuklinska et al., 2010) . In the coronary microvasculature, dysfunction associated with elevated levels of catecholmaines is thought to play an important part in the development of tako-tsubo syndrome, and depressed endothelial cell activity has also been associated with raised sympathetic nerve activity and suggested to involve β-adrenoceptors (De Caterina et al., 2011; Pettersson et al., 1990) . So reducing the endogenous stimulation of vascular β-adrenoceptors could explain in part the beneficial effects of β-blockers (Broeders et al., 2000; Gupta & Wright, 2008; Priviero et al., 2007; Reiter, 2004; Tzemos et al., 2001; Wenzel et al., 2009 ).
In summary, luminal perfusion of β-adrenoceptor agonists causes a significant suppression in endothelium-dependent vasodilation. This action is mediated through β 1 -adrenoceptors, most probably located on the endothelium, and reflects inhibition of endothelial cell IK Ca channels that serves to depresse endothelial cell hyperpolarization. 
